Sign Out
Montelukast sodium is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including the prevention of day- and night-time symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.
Montelukast is indicated for the relief of daytime and night-time symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and paediatric patients 2 years of age and older). Because the benefits of montelukast may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis, reserve use for patients who have an inadequate response or intolerance to alternative therapies.
Continue with Google